United States · 
Who invested in CytoAgents?
CytoAgents's investors include National Institutes of Health, Innovation Works and Richard King Mellon Foundation.
United States · Funded startup
Who invested in CytoAgents
Funding summaryUpdated 26 Oct 2026
$2.3Mraised across 1 round since 2025, from 1 source
- Latest round
- Grant, $2.3MOct 2025
- Investors
- 3
The rounds
- Oct 2025Grant$2.3M
Source recorded
Founders and team
From CytoAgents's own website and the SEC filings it signed: 1 founder, 4 on the team.
Anthony McCarleyFounder & CEO of McCarley InternationalNamed on its 2023 Form D
- Teresa WhalenChief Executive Officer and Presidenti
- Denise GottfriedChief Regulatory and Operations Officer
- Michael HowellChief Science Officer
- Roy L PriebChief Financial Officer
On the board, as filediCatherine MottRobert L FerrisStanley Marks
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
These 4 firms list CytoAgents as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Quick answers about CytoAgents
How much has CytoAgents raised?
CytoAgents has raised $2.3M across 1 round since 2025.
When did CytoAgents last raise?
CytoAgents's most recent round was a Grant of $2.3M in Oct 2025.
What was CytoAgents's biggest round?
Its most recent round, $2.3M in Oct 2025, is also its largest on record.
Who backed CytoAgents first?
CytoAgents's first round on record, in Oct 2025, was backed by National Institutes of Health, Innovation Works and Richard King Mellon Foundation.
What stage is CytoAgents at?
CytoAgents's latest named round is a Grant, in Oct 2025.
Where is CytoAgents based?
CytoAgents is based in the United States.
Companies like CytoAgents
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.